A/Prof Daryl Cheng

Consultant Paediatrician, Department of General Medicine at The Royal Children's Hospital

A/Professor Daryl Cheng lives and practices at the intersection of health, illness, technology and wellbeing. Bringing together his passion for holistic health, informatics, systems thinking and social enterprise, he works across a variety of environments and initiatives to improve life for children and their families.

Dr Patricia Vietheer

Senior Director, R&D Strategy & Planning at Biointelect

At Biointelect, Patricia leads the R&D Strategy & Planning team, supporting a wide range of clients from universities, research institutions, government, start-up companies, biotech, medtech and pharma companies. She has led numerous projects at Biointelect in commercialisation strategy, business case development, planning and execution for key clients. She is particularly passionate about helping clients streamline their path to market using strategic project management techniques and thus commercialising their novel discoveries.

Dr Toby Thompson

Principal of Griffith Hack

Dr Toby Thompson is a patent attorney and Principal of Griffith Hack, based in Melbourne. He specialises in life sciences and chemical inventions, in the areas of pharmaceuticals (e.g. small molecules, protein therapeutics, ADCs), animal healthcare, agrochemicals and chemical processes. Toby advises clients on global IP strategy, patent portfolio management, and patent drafting and prosecution.

Priority Manager of Australia's Economic Accelerator

Joe is the Priority Manager for Medical Science in the Australia’s Economic Accelerator (AEA) Program. Joe has a background in the pharmaceutical industry with 25 years of experience working in a variety of roles in multinational companies, SMEs and Government organisations in Australia, the UK and Asia, including 7 years in research collaboration and commercialisation at CSIRO.

CEO & Co-Founder of Celleo

David Kneen is CEO and co-Founder of Celleo, an Australian company delivering Intelligent Production Systems for Cell Therapy. Celleo’s customers include the world’s leading biopharma’s, CDMOs and clinical cusp novel therapies. The company’s head office and labs are at Melbourne’s Jumar BioIncubator. David is a growth-focused strategy, business operations and commercialisation specialist. He has over 20 years’ experience leading the development and deployment of automated biological production systems – across cell, gene and tissue therapies, ancillary materials, and medical devices. David has supported the manufacturing implementation of many of the world’s approved ATMPs, working with customers worldwide.